In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.

Biomarkers which better match anticancer drugs with cancer driver genes hold the promise of improved clinical responses and cure rates. We developed a precision medicine platform of rapid high-throughput drug screening (HTS) and patient-derived xenografting (PDX) of primary tumor tissue, and evaluated its potential for treatment identification among 56 consecutively enrolled high-risk pediatric cancer patients, compared with conventional molecular genomics and transcriptomics. Drug hits were seen in the majority of HTS and PDX screens, which identified therapeutic options for 10 patients for whom no targetable molecular lesions could be found. Screens also provided orthogonal proof of drug efficacy suggested by molecular analyses and negative results for some molecular findings. We identified treatment options across the whole testing platform for 70% of patients. Only molecular therapeutic recommendations were provided to treating oncologists and led to a change in therapy in 53% of patients, of whom 29% had clinical benefit. These data indicate that in vitro and in vivo drug screening of tumor cells could increase therapeutic options and improve clinical outcomes for high-risk pediatric cancer patients.

Investigation on C2-ceramide complexes with transition metal ions using electrospray ionization tandem mass spectrometry.

Electrospray ionization-tandem mass spectrometry (ESI-MS/MS) is applied for the investigation of C(2)-ceramide complexes with transition metal ions. Ceramide plays an important role in the regulation of various signaling pathways leading to proliferation, differentiation or apoptotic cell death. The formation and fragmentation of doubly charged cluster ions as well as singly charged cluster ions of C(2)-ceramide with transition metal ions (Mn(2+), Fe(2+), Co(2+) and Ni(2+)) are studied by ESI-MS/MS in the positive mode. Tube lens offset voltage and concentrations of C(2)-ceramide and transition metals are optimized to determine the best conditions for generating doubly charged cluster ions. The fragmentation pathways of metal ion complexes with C(2)-ceramide and the compositions of these complexes are determined by collision induced dissociation (CID). All transition metal ions (Mn(2+), Fe(2+), Co(2+) and Ni(2+) except Cu(2+)) shows similar complexation with C(2) ceramide. The unique complexation behavior of copper(II) is responsible for the different geometry of the complexes and relatively lower affinity of ceramide to copper(II) than those to other transition metals.